Abstract

The analysis of screening for adolescent idiopathic scoliosis published by the USPSTF is an important document, both because it reintroduces the task force as an important player in the clinical policies business and because it points (once again) to the deficiencies in our scientific understanding of a relatively common condition. Certainly medicolegal, cost, outcome, and patient preference issues not completely accounted for in the task force analysis need to be included in a fully developed clinical policy for this condition. The findings allow family physicians to use their own judgment pending publication of better and more complete data. On the whole the USPSTF analysis suggests that a nonaggressive approach toward screening is indicated until we have evidence clearly pointing one direction or the other.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.